Australia has approved controversial Alzheimer’s drug lecanemab after two rejections.1 The amyloid hypothesis posits that amyloid is the […]
Category: Uncategorized
Safety warnings for gabapentinoids, benzodiazepines, and non-benzodiazepines (z drugs) are to be strengthened to give doctors and patients […]
Mounjaro: Experts issue warning over black market jabs, with fifth of areas still lacking NHS access
One in five local areas in England still do not provide the weight loss jab tirzepatide (Mounjaro) on […]
Long COVID affects an estimated 65 million people worldwide and can damage the brain, heart, blood vessels, and […]
Scientists are to compare tumour specimens from the 1950s to those from today to try to identify what […]
An artificial intelligence is now allowed legally to participate in clinical decisions over prescription renewals.The approval, made in […]
Updated Date: Thu, 01 Jan 2026 00:00:00 EST
Most of the government’s newly built NHS neighbourhood health centres (NHCs) will be funded by private finance, a […]
The use of glucagon-like peptide-1 (GLP-1) receptor agonist drugs for weight loss is increasing rapidly, with an estimated […]
